101 DEGREES FAHRENHEIT,HODGKIN'S LYMPHOMA,HUMORAL HYPERCALCEMIA OF MALIGNANCY,HYPERCALCEMIA,HYPERCALCEMIA ASSOCIATED WITH METASTATIC BREAST CARCINOMA,HYPERCALCEMIA ASSOCIATED WITH NEOPLASM,HYPERCALCEMIA ASSOCIATED WITH SARCOIDOSIS,HYPERCOAGULABILITY STATES,HYPERKALEMIA,HYPERSENSITIVITY ANGIITIS,HYPERSENSITIVITY PNEUMONITIS,HYPERTHYROIDISM,HYPERURICEMIA,HYPOALBUMINEMIA,HYPOGAMMAGLOBULINEMIA,HYPOGLYCEMIC DISORDER,HYPONATREMIA,HYPOPLASTIC ANEMIA,HYPOXIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IMMUNOCOMPROMISED PATIENTS,IMMUNOSUPPRESSION,INCOMPLETE TESTICULAR DEVELOPMENT,INCREASED CARDIOVASCULAR EVENT RISK,INCREASED CREATINE PHOSPHOKINASE,INCREASED RISK OF BLEEDING,INFECTED ATOPIC DERMATITIS,INFECTION,INFLAMMATORY BOWEL DISEASE,INTERSTITIAL LUNG DISEASE,INTRINSIC ASTHMA,LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION,LEFT VENTRICULAR FAILURE,LEUKEMIA,LEUKOCYTOSIS,LOWER RESPIRATORY INFECTIONS,LUNG TRANSPLANTATION,LUPUS ANTICOAGULANT DISORDER,LYMPHADENOPATHY,LYMPHOID LEUKEMIA,MALABSORPTION STATES,MALE HYPOGONADISM,MALIGNANCY,MALIGNANT BONE DISEASE,MALIGNANT BRAIN NEOPLASM,MALIGNANT LYMPHOMA,MALIGNANT NEOPLASM OF BONE MARROW,MALIGNANT NEOPLASM OF SKIN,MALIGNANT NEOPLASM OF URINARY SYSTEM,MONOCLONAL GAMMOPATHY,MULTIPLE MYELOMA,MULTIPLE SCLEROSIS,MUSCLE WEAKNESS,MYASTHENIA GRAVIS,MYCOSIS FUNGOIDES,MYELODYSPLASTIC SYNDROME,MYOCARDITIS,MYOPATHY,MYOPATHY WITH CK ELEVATION,MYOSITIS,NASAL CONGESTION,NASAL POLYP,NECROTIZING ENTEROCOLITIS,NEOPLASM,NEPHROTIC SYNDROME,NEUROMUSCULAR BLOCKADE,NEUROMUSCULAR DISEASE,NEUROMUSCULAR TRANSMISSION DEFICIENCY,NEUROPATHY,NON-HODGKIN'S LYMPHOMA,NUTRITIONAL DISORDER,OBSTRUCTIVE BRONCHIOLITIS,OBSTRUCTIVE PULMONARY DISEASE,OCCLUSIVE VASCULAR DISEASE,OCULAR DISORDERS,OCULAR INFLAMMATION,OLIGURIA,OPTIC NEURITIS,ORAPRED,ORAPRED ODT,ORGAN TRANSPLANT WITH IMMUNOSUPPRESSIVE THERAPY,ORGANIC CARDIAC DISEASE,OSTEOLYTIC NEOPLASM,OTITIS EXTERNA ECZEMA,PARASITIC INFECTION,PEMPHIGUS,PERICARDIAL EFFUSION,PERICARDITIS,PERIPHERAL MOTOR NEUROPATHY,PERIPHERAL NEUROPATHY,PERIPHERAL VASCULAR DISEASE,PERNICIOUS ANEMIA,PHLEBITIS,PLAQUE PSORIASIS,PNEUMOCYSTIS CARINII PNEUMONIA,PNEUMONIA,PRE-EXISTING FLUID RETENTION,PREDISPOSITION TO GI HEMORRHAGE,PREDISPOSITION TO THROMBOSIS,PREDNISOLONE SOD PHOSPHATE,PRIMARY ADRENOCORTICAL INSUFFICIENCY,PROCTITIS,PROSTATIC CARCINOMA,PROTEINURIA,PROTOZOAL INFECTION,PRURITUS OF SKIN,PSORIASIS,PULMONARY CONGESTION,PULMONARY DISEASE,PULMONARY EDEMA,PULMONARY EMPHYSEMA,PULMONARY FIBROSIS,PULMONARY INFILTRATES,PURPURA,PUSTULAR PSORIASIS,RAW SKIN,RENAL DISEASE,RENAL DISEASE WITH MILD TO MODERATE RENAL FUNCTION IMPAIRMENT,RENAL FAILURE,RENAL TRANSPLANT,REPRODUCTIVE SYSTEM DISORDER,RHEUMATOID ARTHRITIS,SALIVARY SECRETION DISORDER,SARCOIDOSIS,SECONDARY MALIGNANT NEOPLASM OF BONE MARROW,SECONDARY MALIGNANT NEOPLASM OF LYMPH NODES,SEPTIC THROMBOPHLEBITIS,SEVERE ADRENAL INSUFFICIENCY,SEVERE ALLERGIC RHINITIS,SEVERE ANEMIA,SEVERE BONE MARROW DEPRESSION,SEVERE CARDIAC DISEASE,SEVERE CARDIOVASCULAR DISEASE,SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SEVERE COAGULATION DEFECTS,SEVERE CROHN'S DISEASE,SEVERE DIARRHEA,SEVERE HYPOXEMIA,SEVERE INFECTION,SEVERE RENAL DISEASE,SEVERE THROMBOCYTOPENIA,SEVERE ULCERATIVE COLITIS,SHIONOGI PHARMA,SHOULDER TENDONITIS,SIGNIFICANT BLEEDING,SJOGREN'S SYNDROME,SKIN AND SKIN STRUCTURE NEOPLASM,SKIN INFLAMMATION,SKIN IRRITATION,SKIN PHOTOSENSITIVITY,SKIN RASH,SKIN ULCER,STATUS ASTHMATICUS,STEATORRHEA,STEVENS-JOHNSON SYNDROME,SUBACUTE INFECTIVE ENDOCARDITIS,SUPERFICIAL SKIN ULCER,SURGICAL OR OTHER PROCEDURE,SYSTEMIC LUPUS ERYTHEMATOSUS,TEAR FILM INSUFFICIENCY,TENDONITIS,THROMBOCYTOPENIC DISORDER,THROMBOPHLEBITIS,THROMBOPHLEBITIS MIGRANS,THROMBOSIS IN HEPARIN INDUCED THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THYROIDITIS,TOXIC EPIDERMAL NECROLYSIS,TRANSPLANTATION PROCEDURE,ULCERATION OF COLON,ULCERATION OF INTESTINE,ULCERATIVE COLITIS,ULCERATIVE PROCTITIS,UNCONTROLLED BACTERIAL INFECTIONS,UNCONTROLLED COAGULATION DEFECTS,UNTREATED BACTERIAL INFECTION,UNTREATED FUNGAL INFECTION,URTICARIA,UVEITIS,VASCULITIS,VERTEBRAL METASTASES,VITILIGO,WHEEZING'/> Orapred Odt

ORAPRED ODT (prednisolone sod phosphate)


Drug overview for ORAPRED ODT (prednisolone sod phosphate):

Generic name: PREDNISOLONE SOD PHOSPHATE
Drug class:
Therapeutic class:

No enhanced Introduction information available for this drug.

 No enhanced Uses information available for this drug.
DRUG IMAGES
  • No Image Available
    No Image Available
The following indications for ORAPRED ODT (prednisolone sod phosphate) have been approved by the FDA:

Indications:
None.

Professional Synonyms:
None.